Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Asymptomatic hyperuricaemia and allopurinol induced toxic epidermal necrolysis.

Literature DB >> 3924329

Asymptomatic hyperuricaemia and allopurinol induced toxic epidermal necrolysis.

J Auböck, P Fritsch.

Abstract

Entities: Chemical

Mesh：

Substances：
Uric Acid
Allopurinol

Year: 1985 PMID： 3924329 PMCID： PMC1416029 DOI： 10.1136/bmj.290.6486.1969

Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN： 0267-0623

× No keyword cloud information.

11 in total

1. Hyperuricaemia--to treat or not?

Authors: B T Emmerson
Journal: Drugs Date: 1975 Impact factor: 9.546

Review 2. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal.

Authors: A Lyell
Journal: Br J Dermatol Date: 1979-01 Impact factor: 9.302

3. Toxic epidermal necrolysis, azotemia, and death after allopurinol therapy.

Authors: G L Kantor
Journal: JAMA Date: 1970-04-20 Impact factor: 56.272

4. Acute adverse reactions attributed to allopurinol in hospitalised patients.

Authors: G T McInnes; D H Lawson; H Jick
Journal: Ann Rheum Dis Date: 1981-06 Impact factor: 19.103

5. Toxic epidermal necrolysis associated with allopurinol administration.

Authors: M H Ellman; D F Fretzin; W Olson
Journal: Arch Dermatol Date: 1975-08

6. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency.

Authors: K R Hande; R M Noone; W J Stone
Journal: Am J Med Date: 1984-01 Impact factor: 4.965

7. Asymptomatic hyperuricemia: the case for conservative management.

Authors: M H Liang; J F Fries
Journal: Ann Intern Med Date: 1978-05 Impact factor: 25.391

8. Allopurinol-induced toxic epidermal necrolysis.

Authors: M Dan; M Jedwab; M Peled; S Shibolet
Journal: Int J Dermatol Date: 1984-03 Impact factor: 2.736

9. The allopurinol hypersensitivity syndrome.

Authors: G P Lupton; R B Odom
Journal: J Am Acad Dermatol Date: 1979-10 Impact factor: 11.527

10. Management of asymptomatic hyperuricemia.

Authors: W B Duffy; H O Senekjian; T F Knight; E J Weinman
Journal: JAMA Date: 1981-11-13 Impact factor: 56.272

9 in total

1. Asymptomatic hyperuricaemia.

Authors: J T Scott
Journal: Br Med J (Clin Res Ed) Date: 1987-04-18

2. Allopurinol hypersensitivity syndrome revisited.

Authors: T Elasy; D Kaminsky; M Tracy; P S Mehler
Journal: West J Med Date: 1995-04

3. Allopurinol, erythema multiforme, and renal insufficiency.

Authors: A Kumar; N Edward; M I White; P W Johnston; G R Catto
Journal: BMJ Date: 1996-01-20

4. Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes.

Authors: Hong Ki Min; Boin Lee; Seung-Ki Kwok; Ji Hyeon Ju; Wan-Uk Kim; Young Min Park; Sung-Hwan Park
Journal: Korean J Intern Med Date: 2015-06-29 Impact factor: 2.884

5. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.

Authors: Shuen-Iu Hung; Wen-Hung Chung; Lieh-Bang Liou; Chen-Chung Chu; Marie Lin; Hsien-Ping Huang; Yen-Ling Lin; Joung-Liang Lan; Li-Cheng Yang; Hong-Shang Hong; Ming-Jing Chen; Ping-Chin Lai; Mai-Szu Wu; Chia-Yu Chu; Kuo-Hsien Wang; Chien-Hsiun Chen; Cathy S J Fann; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal: Proc Natl Acad Sci U S A Date: 2005-03-02 Impact factor: 11.205